Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events

Aims. To study influence of combined treatment with human insulin analogues (insulin aspart and insulin detemir) on glycemic control,insulin resistance and development of ischaemic heart disease (IHD) in patients with type 2 diabetes mellitus (T2DM) and frequenthypoglycemic events in comparison wit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vladimir Ivanovich Kudinov, Maria Sergeevna Nichitenko, Anna Ivanovna Chesnikova, Natalya Vladimirovna Zolotareva
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	diabetes mellitus type 2 hypoglycemia ischaemic heart disease insulin analogues Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/4cf0495a3c58447d9bb9c9793f5248a6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4cf0495a3c58447d9bb9c9793f5248a6
record_format	dspace
spelling	oai:doaj.org-article:4cf0495a3c58447d9bb9c9793f5248a62021-11-14T09:00:17ZComparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events2072-03512072-037810.14341/2072-0351-5514https://doaj.org/article/4cf0495a3c58447d9bb9c9793f5248a62012-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5514https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aims. To study influence of combined treatment with human insulin analogues (insulin aspart and insulin detemir) on glycemic control,insulin resistance and development of ischaemic heart disease (IHD) in patients with type 2 diabetes mellitus (T2DM) and frequenthypoglycemic events in comparison with that of human insulins (soluble and isophane). Materials and methods. 54 patients (mean age 61.2?0.7) with T2DM and IHD participated in this study. All included patients experiencedfrequent mild and moderate hypoglycemic events (3+ episodes per week). We analyzed frequency and severity of hypoglycemia,parameters of glycemic and lipid metabolism, number of ischaemic episodes per day, duration and depth of ST depression, circadianindex, incidence of different types of arrhythmia and conduction abnormalities as measured by Holter ECG monitoring.All patients were subdivided into two groups by random sampling: 21 patient (first group) carried on with human soluble insulin andisophane in an optimized basal-bolus regimen. In 33 patients, comprising second group, treatment was changed for combination ofinsulin aspart (NovoRapid?, Novo Nordisk, Denmark) and insulin detemir (Levemir?, Novo Nordisk, Denmark). Follow-up periodwas set to 6 months. Results. In patients with frequent hypoglycemic experience different types of arrhythmia and heart conduction abnormalities wereobserved in 75.9% of cases. Most patients had complex types of arrhythmic disorders (70.4%) with ventricular extrasystole being themost common one. Signs of myocardial ischaemia were registered in 48.1% of patients.After 6 months of follow-up patients from the second group demonstrated a statistically significant decrease in fasting and postprandiallevels of glycemia (p=0.000001). Both groups also had a significantly lower rate of hypoglycemic events. Moreover, in the second groupall episodes of hypoglycemia were mild and occurred only in 36.4% of cases. Additionally, after 6 months of treatment with humaninsulin analogues ventricular extrasystoles were registered only in 24.2% of patients, while rate and duration of ischaemic episodesdropped to 4.25?1.51 (p=0.012, comparing with first group). Conclusion. Treatment with human insulin analogues NovoRapid? and Levemir? is associated with 1.6% decrease in HbA1c levels.Mild hypoglycemia was 72.2% less frequent, as compared with rates in the group on human soluble and isophane insulin, while moderateand severe hypoglycemic events were not observed at all. In turn, decrease in frequency and severity of hypoglycemia was associatedwith substantial improvement in cardiovascular status due to lower number and duration of ischaemic episodes (including painlessvariant) and lower frequency of heart rhythm disorders.Vladimir Ivanovich KudinovMaria Sergeevna NichitenkoAnna Ivanovna ChesnikovaNatalya Vladimirovna ZolotarevaEndocrinology Research Centrearticlediabetes mellitus type 2hypoglycemiaischaemic heart diseaseinsulin analoguesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 2, Pp 22-26 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 hypoglycemia ischaemic heart disease insulin analogues Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 hypoglycemia ischaemic heart disease insulin analogues Nutritional diseases. Deficiency diseases RC620-627 Vladimir Ivanovich Kudinov Maria Sergeevna Nichitenko Anna Ivanovna Chesnikova Natalya Vladimirovna Zolotareva Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
description	Aims. To study influence of combined treatment with human insulin analogues (insulin aspart and insulin detemir) on glycemic control,insulin resistance and development of ischaemic heart disease (IHD) in patients with type 2 diabetes mellitus (T2DM) and frequenthypoglycemic events in comparison with that of human insulins (soluble and isophane). Materials and methods. 54 patients (mean age 61.2?0.7) with T2DM and IHD participated in this study. All included patients experiencedfrequent mild and moderate hypoglycemic events (3+ episodes per week). We analyzed frequency and severity of hypoglycemia,parameters of glycemic and lipid metabolism, number of ischaemic episodes per day, duration and depth of ST depression, circadianindex, incidence of different types of arrhythmia and conduction abnormalities as measured by Holter ECG monitoring.All patients were subdivided into two groups by random sampling: 21 patient (first group) carried on with human soluble insulin andisophane in an optimized basal-bolus regimen. In 33 patients, comprising second group, treatment was changed for combination ofinsulin aspart (NovoRapid?, Novo Nordisk, Denmark) and insulin detemir (Levemir?, Novo Nordisk, Denmark). Follow-up periodwas set to 6 months. Results. In patients with frequent hypoglycemic experience different types of arrhythmia and heart conduction abnormalities wereobserved in 75.9% of cases. Most patients had complex types of arrhythmic disorders (70.4%) with ventricular extrasystole being themost common one. Signs of myocardial ischaemia were registered in 48.1% of patients.After 6 months of follow-up patients from the second group demonstrated a statistically significant decrease in fasting and postprandiallevels of glycemia (p=0.000001). Both groups also had a significantly lower rate of hypoglycemic events. Moreover, in the second groupall episodes of hypoglycemia were mild and occurred only in 36.4% of cases. Additionally, after 6 months of treatment with humaninsulin analogues ventricular extrasystoles were registered only in 24.2% of patients, while rate and duration of ischaemic episodesdropped to 4.25?1.51 (p=0.012, comparing with first group). Conclusion. Treatment with human insulin analogues NovoRapid? and Levemir? is associated with 1.6% decrease in HbA1c levels.Mild hypoglycemia was 72.2% less frequent, as compared with rates in the group on human soluble and isophane insulin, while moderateand severe hypoglycemic events were not observed at all. In turn, decrease in frequency and severity of hypoglycemia was associatedwith substantial improvement in cardiovascular status due to lower number and duration of ischaemic episodes (including painlessvariant) and lower frequency of heart rhythm disorders.
format	article
author	Vladimir Ivanovich Kudinov Maria Sergeevna Nichitenko Anna Ivanovna Chesnikova Natalya Vladimirovna Zolotareva
author_facet	Vladimir Ivanovich Kudinov Maria Sergeevna Nichitenko Anna Ivanovna Chesnikova Natalya Vladimirovna Zolotareva
author_sort	Vladimir Ivanovich Kudinov
title	Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
title_short	Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
title_full	Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
title_fullStr	Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
title_full_unstemmed	Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
title_sort	comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/4cf0495a3c58447d9bb9c9793f5248a6
work_keys_str_mv	AT vladimirivanovichkudinov comparativeefficacyassessmentforvariousinsulinregimensinpatientswithtype2diabetesmellitusischaemicheartdiseaseandfrequenthypoglycemicevents AT mariasergeevnanichitenko comparativeefficacyassessmentforvariousinsulinregimensinpatientswithtype2diabetesmellitusischaemicheartdiseaseandfrequenthypoglycemicevents AT annaivanovnachesnikova comparativeefficacyassessmentforvariousinsulinregimensinpatientswithtype2diabetesmellitusischaemicheartdiseaseandfrequenthypoglycemicevents AT natalyavladimirovnazolotareva comparativeefficacyassessmentforvariousinsulinregimensinpatientswithtype2diabetesmellitusischaemicheartdiseaseandfrequenthypoglycemicevents
_version_	1718429579929976832

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events

Ejemplares similares